NCT04931524View on ClinicalTrials.gov

A Study to Assess the Absorption, Metabolism and Excretion of [14C]-ANG-3777

PHASE1UnknownINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 21, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Healthy
Interventions
DRUG

carbon-14-[14C]-ANG-3777

Arms assigned to this intervention will receive 240 mg, IV and not more than 5.2 MBq, Fasted

Trial Locations (1)

NG11 6JS

RECRUITING

Quotient Sciences, Nottingham

Sponsors
All Listed Sponsors
collaborator

Quotient Sciences

INDUSTRY

lead

Angion Biomedica Corp

INDUSTRY

NCT04931524 - A Study to Assess the Absorption, Metabolism and Excretion of [14C]-ANG-3777 | Biotech Hunter | Biotech Hunter